Headquartered in Hyderabad, at the heart of India’s pharmaceutical ecosystem, AltiusHub is building a modern supply chain traceability platform designed for industries where trust, compliance, and product integrity are mission critical. While global industries are moving at an unprecedented pace, many supply chain systems continue to rely on fragmented processes, siloed data, and reactive workflows. In sectors such as pharmaceuticals, life sciences, defence, fine chemicals, and luxury goods, these gaps can have serious consequences.

At AltiusHub, we believe supply chain traceability cannot remain stuck in legacy systems. The world is evolving rapidly with AI-first technologies and real-time decision-making becoming the new standard. Our platform combines modern SaaS infrastructure, and AI capabilities to help businesses gain end-to-end visibility across the product journey, from manufacturing to distribution and final sale.

‍

Abiram Vijayakumar, our cofounder said - “AltiusHub was born out of a deep-seated concern with the vulnerabilities in traditional supply chains. We saw firsthand the devastating consequences of counterfeit products, particularly in industries like pharmaceuticals. Our vision is to create a technology that would not only enhance supply chain visibility but also provide a proactive defence against counterfeit threats. We believe that by empowering businesses with the technology they need to protect their brands and safeguard consumer safety, we can make a significant impact on the global marketplace."

‍

As global compliance frameworks continue to evolve, including regulations such as US DSCSA, EU FMD, UAE Tatmeen, and India’s iVeda, pharma enterprises increasingly need technology platforms that are scalable, intelligent, and built for interoperability. We believe the future of supply chain traceability will be driven by real-time visibility, automation, and AI-powered intelligence rather than manual reconciliation and fragmented systems.

The global track-and-trace market is projected to reach $7.3 billion by 2026, driven by increasing regulatory requirements and growing demand for secure supply chains. We see this as a significant opportunity to help enterprises modernize how they approach traceability, compliance, and operational resilience.

‍

Sateesh Andra, Managing Partner, Endiya Partners said - “As India's pharma exports expand, ensuring compliance, visibility, and efficiency across the supply chain is crucial. AltiusHub’s advanced SaaS platform empowers pharma companies to track and trace products from production to final sale while adhering to global regulatory standards. We are excited to partner with Siddharth and Abiram, founders who bring deep domain expertise and an unwavering passion for addressing critical issues in supply chain traceability and compliance.”

‍

The founding team brings together deep expertise across pharmaceuticals, supply chain operations, and enterprise SaaS.

Siddharth Reddy, an alumnus of BITS Pilani and ESCP Europe, has over a decade of experience across pharma, life sciences, and SaaS. Abiram Vijayakumar, an alumnus of Anna University and TISS, brings prior experience from KPMG and Maruti Suzuki across supply chain and operational systems.

Together, the founders experienced firsthand how legacy systems struggle to keep up with the growing complexity of modern global supply chains.

‍

This funding marks the beginning of a larger journey for AltiusHub. We are building toward a future where supply chains are not only compliant, but intelligent, adaptive, and proactive by design. We are grateful to Endiya Partners, our early supporters, customers, and well-wishers who believe in our mission.

The road ahead is ambitious, and we are just getting started.